LONGEVA.

CJC-1295 no-DAC reference dosing

cjc-1295 no dac dosage

> Updated:

In short

CJC-1295 without DAC (Mod GRF 1-29) is a GHRH analog with a half-life of minutes, so described regimens are small and frequent: about 100 mcg (≈1 mcg/kg) subcutaneously 1–3 times a day, up to 300 mcg per injection, usually fasted. This form has no prolonging DAC component – which is exactly why it is injected daily rather than once a week.

Human dosing

CJC-1295 no DAC dosing is more frequent and lower per injection than the DAC variant, because this form lacks the DAC lipid extension that prolongs release: the schedule below draws on described protocols and pharmacokinetic data, not an individual recommendation.

Period / conditionDoseEscalation
Saturation dose (per injection)~100 mcg (≈1 mcg/kg)Starting dose
Standard regimen100 mcg subcutaneously, 1–3x/dayIncrease if needed
Upper end of regimenup to 300 mcg per injectionMaximum in this schedule
Practical dosing and effect details

CJC-1295 no DAC (Mod GRF 1-29) is a growth hormone-releasing hormone (GHRH) analog without the prolonging lipid "anchor" DAC. Because of this its serum half-life is measured in minutes, not days like the DAC variant. That is why described protocols keep injection frequency high, up to several times a day, instead of one large weekly dose: the short concentration peak has to be reproduced repeatedly to keep stimulating the pituitary.

The saturation dose on this page (about 100 mcg) and the upper bound (up to 300 mcg per injection) reflect the same logic: small repeated doses rather than one large one, because the compound clears fast. The fasted administration noted above relates to insulin after a meal blunting the growth-hormone pulse that a GHRH analog stimulates; this pattern is established growth-hormone pharmacology, not a quirk of this particular protocol.

This is reference information on regimens from published sources, not a medical recommendation.

Frequently asked questions

How does the no-DAC form differ from CJC-1295 with DAC? By duration of action. DAC is a lipid "anchor" that keeps the DAC variant in the blood for days, so it is injected 1–2 times a week; the no-DAC form clears within minutes, and the peak has to be repeated 1–3 times a day. The DAC variant schedule is in a separate reference.

Is CJC-1295 without DAC combined with ipamorelin? Yes, it is the most common combination in search demand: both peptides act on the growth-hormone axis from different sides – CJC-1295 amplifies the GHRH signal, ipamorelin acts through ghrelin receptors. In described regimens they are injected subcutaneously at the same time, about 100 mcg of each; the ipamorelin regimen is in its reference.

How many syringe units is 100 mcg? It depends on the reconstitution. Example: a 5 mg vial reconstituted with 2 ml of bacteriostatic water gives 2.5 mg/ml – then 100 mcg is 0.04 ml, or 4 units on a U-100 syringe. A different water volume means different units; the reconstitution calculator gives the exact figure.

Research protocols

CJC-1295 no-DAC reference dosing: reference regimens

CJC-1295 without DAC (Mod GRF 1-29) is given by subcutaneous injection, usually fasted.